Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
latest_posts
- 1
Find Successful Magnificence Items for Sparkling Skin - 2Man triggers smoke bomb during failed crypto robbery
- 3Become the best at Discussion: 6 Procedures for Progress
- 4Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds
- 5Figure out How to Put resources into Lab Precious stones
- Famous Rough terrain Vehicles for 2024
- A rare whale is having an encouraging season for births. Scientists warn it might still go extinct
- Instructions to Utilize the Towing Highlights of the Slam 1500 Productively.
- Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide
- AI’s errors may be impossible to eliminate – what that means for its use in health care
- True serenity: Investigating Emotional well-being and the Advantages of Contemplation
- 'I carried my wife's body for an hour and a half' - BBC hears stories of protesters killed in Iran
- ‘Integral part of our nation’: Herzog visits Franciscan Sisters in Jerusalem ahead of Christmas
- US FDA declines to approve Corcept's drug for rare hormonal disorder
